Follow
Sweta Chakraborty
Sweta Chakraborty
We Don't Have Time
Verified email at wedonthavetime.org
Title
Cited by
Cited by
Year
The changing nature of communication and regulation of risk in Europe
R Lofstedt, F Bouder, J Wardman, S Chakraborty
Journal of Risk Research 14 (4), 409-429, 2011
1022011
Risk communication and the pharmaceutical industry
B Edwards, S Chakraborty
Drug safety 35 (11), 1027-1040, 2012
302012
How risk perceptions, not evidence, have driven harmful policies on COVID-19
S Chakraborty
European Journal of Risk Regulation 11 (2), 236-239, 2020
272020
The future of risk communication and the role of the pharmaceutical industry
S Chakraborty, F Bouder
Current drug safety 8 (1), 4-10, 2013
152013
Transparency Initiative by the FDA’s Center for Drug Evaluation and Research (CDER): Two qualitative studies of Public Perceptions
S Chakraborty, R Lofstedt
European Journal of Risk Regulation 3 (1), 57-71, 2012
152012
Part I: The role of trust in patient noncompliance: a qualitative case study of users of statins for the chronic treatment of high-cholesterol in New York City
S Chakraborty
Journal of Risk Research 16 (1), 97-112, 2013
122013
Transparency and the Food and Drug Administration—A quantitative study
R Lofstedt, F Bouder, S Chakraborty
Journal of health communication 18 (4), 391-396, 2013
112013
Part II: the role of trust in patient noncompliance: a quantitative case study of users of statins for the chronic treatment of high cholesterol in New York City
S Chakraborty
Journal of Risk Research 16 (1), 113-129, 2013
72013
Predictably irrational consumer food preferences
J Bobo, S Chakraborty
European Journal of Risk Regulation 7 (3), 604-609, 2016
62016
Risk communication and transparency: a quantitative study
R Löfstedt, F Bouder, S Chakraborty
Journal of Health Communication: International Perspectives 18 (4), 391-396, 2013
62013
Pink slime, raw milk and the tweetification of risk
J Bobo, S Chakraborty
European Journal of Risk Regulation 6 (1), 141-144, 2015
52015
The changing nature of regulation and communication of risk in Europe
R Löfstedt, F Bouder, JK Wardman, S Chakraborty
Journal of Risk Research 14 (4), 409-429, 2011
52011
Challenges and opportunities of omnichannel retailing
S Chakraborty, I Chung
European Journal of Risk Regulation 5 (3), 386-388, 2014
42014
2010 Meltdown–Airport Closure Risk Communications in London and NYC
S Chakraborty, N Creutzfeldt-Banda
European Journal of Risk Regulation 2 (1), 108-110, 2011
42011
The challenge of emergency risk communication: lessons learned in trust and risk communication from the volcanic ash crisis
S Chakraborty
The challenges of emergency risk regulation. Cheltenham and Northampton …, 2011
42011
Risk and crisis communication recommendations for industry based on advances in cognitive behavioral science research
S Chakraborty
European Journal of Risk Regulation 5 (2), 238-241, 2014
32014
The Risk vs hazard debate: reconciling inconsistencies in health & safety regulation within the UK and across the EU
S Chakraborty
32012
Pharmaceutical and medical device safety: a study in public and private regulation
S Macleod, S Chakraborty
Bloomsbury Publishing, 2019
22019
Pink Slime versus Garbage Chic: A Consideration of the Impact of Framing on Consumer Behavior Towards Food Waste
J Bobo, S Chakraborty
European Journal of Risk Regulation 6 (3), 445-447, 2015
22015
Transparency and the food and drug administration-A quantitative study
R Löfstedt, F Bouder, S Chakraborty
Journal of Health Communication: International Perspectives 18 (4), 391-396, 2013
22013
The system can't perform the operation now. Try again later.
Articles 1–20